Insilico Signs Massive $2.5B Partnership with SK Biopharmaceuticals for Neuroimmune Therapies
Insilico Medicine and SK Biopharmaceuticals have announced a strategic global research and development collaboration at the BIO 2026 International Convention. The partnership aims to discover...
Sun Pharma Acquires Checkpoint Therapeutics in ₹2,480 Crore Global Expansion Move
Sun Pharmaceutical Industries Limited, one of the world’s leading pharmaceutical giants, announced a definitive agreement to acquire Checkpoint Therapeutics in a transaction valued at...
FDA Approves Utebzi for Complicated Urinary Tract Infections
GSK plc and Spero Therapeutics announced that the US Food and Drug Administration (FDA) has approved Utebzi(tebipenem pivoxil). It is indicated for adult patients with complicated urinary tract...
Lupin Introduces Azilsartan Medoxomil Tablets in the United States
Lupin Limited (Lupin) the Indian Global pharmaceuticals major announced that the company will launch Azilsartan Medoxomil Tablets, 40mg and 80mg in the United States, which got approval from the U.S. byAbbreviated New Drug Application (ANDA).
This is a bioequivalent product of Edarbi® produces byAzurity Pharmaceuticals,...
Health Ministry Bans 16 Fixed Dose Combination Drugs to Safeguard Public Health
In a major move to protect public health, the Union Ministry of Health and Family Welfare has banned the manufacture, sale, and distribution of...
Alembic wins USFDA approval for Generic Binimetinib
Alembic Pharmaceuticals Limited (Alembic) announced that it has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application...